Vali Nanomedical

Vali is a venture-backed biotechnology startup founded in 2013 to develop smart, programmable drug delivery systems. Our patent-pending multidrug-delivery platform technology can transport multiple drugs to tumors simultaneously, unlocking previously impossible cancer combination therapies. We can deliver therapeutic nucleotides (siRNA, mRNA, DNA) in addition to traditional small molecule drugs. Our next generation technology will activate payloads only when they are delivered to the correct cell type, giving an unprecedented level of specificity, efficacy and safety.

REQUEST INTRODUCTION USING

LINKEDIN ANGELLIST

COMPANY PEOPLE

Andrew Gray

Andrew Gray
Cofounder and Chief Executive Officer at Vali Nanomedical Corporation

Pin Wang

Pin Wang
Co-Founder at Vali Nanomedical

YOU MIGHT ALSO BE INTERESTED IN